ArticleFrontiers in pharmacology2021

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis.

Weimou Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.